Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2021 | iPSC models of neurodegenerative disease

Selina Wray, PhD, University College London, London, UK, discusses the advantages of using induced pluripotent stem cells (iPSC) models, such as the possibility to make patient-specific models. iPSC can be generated from patients with a genotype and/or phenotype of interest and subsequently be used to generate cerebral organoids. Prof. Wray discusses the use of 2D cortical neurons and 3D cerebral organoids to model neurodegenerative disease, including their opportunities and challenges. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.